Literature DB >> 11567988

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.

C Kollman1, C W Howe, C Anasetti, J H Antin, S M Davies, A H Filipovich, J Hegland, N Kamani, N A Kernan, R King, V Ratanatharathorn, D Weisdorf, D L Confer.   

Abstract

The National Marrow Donor Program (NMDP) maintains a registry of approximately 4 million volunteer unrelated donors for patients in need of a stem cell transplant. When several comparably HLA-matched volunteers are identified for a patient, various criteria are used to select a donor. A retrospective analysis of 6978 bone marrow transplantations facilitated by the NMDP from 1987 to 1999 was conducted to study the effects of various donor characteristics on recipient outcome. The evaluation addressed possible effects of donor age, cytomegalovirus serologic status, ABO compatibility, race, sex, and parity on overall and disease-free survival, acute and chronic graft-versus-host disease (GVHD), engraftment, and relapse. Age was the only donor trait significantly associated with overall and disease-free survival. Five-year overall survival rates for recipients were 33%, 29%, and 25%, respectively, with donors aged 18 to 30 years, 31 to 45 years, and more than 45 years (P =.0002). A similar effect was observed among HLA-mismatched cases (28%, 22%, and 19%, respectively). A race mismatch between recipient and donor did not affect outcome. The cumulative incidences of grade III or IV acute GVHD were 30%, 34%, and 34%, respectively, with donors aged 18 to 30 years, 31 to 45 years, and more than 45 years (P =.005). The corresponding incidences of chronic GVHD at 2 years were 44%, 48%, and 49% (P = 0.02). Recipients with female donors who had undergone multiple pregnancies had a higher rate of chronic GVHD than recipients with male donors (54% versus 44%; P <.0001). The use of younger donors may lower the incidence of GVHD and improve survival after bone marrow transplantation. Age should be considered when selecting among comparably HLA-matched volunteer donors.

Entities:  

Mesh:

Year:  2001        PMID: 11567988     DOI: 10.1182/blood.v98.7.2043

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  186 in total

1.  Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Authors:  Olivia J Holland; Caitlin Linscheid; Herbert C Hodes; Traci L Nauser; Melissa Gilliam; Peter Stone; Larry W Chamley; Margaret G Petroff
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

Review 2.  The immune system in the aging human.

Authors:  Paulina Dominika Rymkiewicz; Yi Xiong Heng; Anusha Vasudev; Anis Larbi
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.

Authors:  Vincent T Ho; Haesook T Kim; Julie Aldridge; Deborah Liney; Grace Kao; Philippe Armand; John Koreth; Corey Cutler; Jerome Ritz; Joseph H Antin; Robert J Soiffer; Edwin P Alyea
Journal:  Biol Blood Marrow Transplant       Date:  2010-12-27       Impact factor: 5.742

4.  Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes.

Authors:  Hideki Nakasone; Bita Sahaf; Lu Tian; Tao Wang; Michael D Haagenson; Kelsi Schoenrock; Spenser Perloff; Christine E Ryan; Fang Wu; Stephen R Spellman; Stephanie J Lee; Jerome Ritz; David B Miklos
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

Review 5.  The aging hematopoietic stem cell niche: Phenotypic and functional changes and mechanisms that contribute to hematopoietic aging.

Authors:  Sarah E Latchney; Laura M Calvi
Journal:  Semin Hematol       Date:  2016-10-19       Impact factor: 3.851

6.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

Review 7.  Mixing old and young: enhancing rejuvenation and accelerating aging.

Authors:  Ashley Lau; Brian K Kennedy; James L Kirkland; Stefan G Tullius
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

8.  Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow Transplantation.

Authors:  Christiane Dobbelstein; Kwang Woo Ahn; Michael Haagenson; Gregory A Hale; Jon J van Rood; David Miklos; Edmund K Waller; Stephen R Spellman; Marcelo Fernandez-Vina; Arnold Ganser; Mahmoud Aljurf; Martin Bornhaeuser; Vikas Gupta; Susan R Marino; Marilyn S Pollack; Vijay Reddy; Matthias Eder; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-01       Impact factor: 5.742

9.  Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Authors:  David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

Review 10.  Modeling human hematopoietic stem cell biology in the mouse.

Authors:  Stephen M Sykes; David T Scadden
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.